UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | H | J | K | L | M | N | O | P | R | S | T | V | W | Y
Number of items: 118.

A

Aballéa, S and Chancellor, JV and Raikou, M and Drummond, MF and Weinstein, MC and Jourdan, S and Bridgewater, J (2007) Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Cancer , 109 (6) 1082 - 1089. 10.1002/cncr.22512.

Allen, OR and Gott, AL and Hartley, JA and Hartley, JM and Knox, RJ and McGowan, PC (2007) Functionalised cyclopentadienyl titanium compounds as potential anticancer drugs. DALTON T (43) 5082 - 5090. 10.1039/b708283p.

Alonzi, R and Padhani, AR and Taylor, NJ and Stirling, JJ and Saunders, MI and Hoskin, PJ (2007) Physiological changes within the prostate caused by androgen withdrawal. In: CLINICAL ONCOLOGY. (pp. S6 - S6).

Arkenau, HT and Chong, G and Cunningham, D and Watkins, D and Agarwal, R and Sirohi, B and Trumper, M and Norman, A and Wotherspoon, A and Horwich, A (2007) The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma. Ann Oncol , 18 (3) 541 - 545. 10.1093/annonc/mdl434.

Arkenau, HT and Chong, G and Cunningham, D and Watkins, D and Sirohi, B and Chau, I and Wotherspoon, A and Norman, A and Horwich, A and Matutes, E (2007) Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. Haematologica , 92 (2) 271 - 272.

Arkenau, HT and Chua, YJ and Cunningham, D (2007) Current treatment strategies in elderly patients with metastatic colorectal cancer. Clin Colorectal Cancer , 6 (7) 508 - 515.

Arkenau, HT and Gordon, C and Cunningham, D and Norman, A and Wotherspoon, A and Chau, I (2007) Mucosa associated lymphoid tissue lymphoma of the lung: the Royal Marsden Hospital experience. Leuk Lymphoma , 48 (3) 547 - 550. 10.1080/10428190601094388.

Arkenau, HT and Gordon, C and Murphy, F and Cunningham, D (2007) Paraneoplastic syndrome: subacute cerebellar degeneration in Hodgkin's disease. Leuk Lymphoma , 48 (4) 819 - 822. 10.1080/10428190601164249.

Ayaru, L and Pereira, SP and Alisa, A and Pathan, AA and Williams, R and Davidson, B and Burroughs, AK and Meyer, T and Behboudi, S (2007) Unmasking of alpha-fetoprotein-specific CD4(+) T cell responses in hepatocellular carcinoma patients undergoing embolization. J IMMUNOL , 178 (3) 1914 - 1922.

B

Bajwa, A and Blunt, N and Vyas, S and McKenzie, G and Bridgewater, J and Hochhauser, D and Obichere, A (2007) Predictive factors of outcome in patients with asymptomatic stage IV colorectal cancer and irresectable liver metastases. In: Annals of Oncology. (pp. V1170 - V1170).

Begent, RHJ and Sharma, SK and Mayer, A and Tolner, B and Pedley, RB and Wilkins, D and Kogelberg, H and Chester, KA (2007) Incorporating single chain Fv antibodies into therapeutic proteins: issues exemplified in antibody-directed enzyme prodrug therapy (ADEPT). In: IMMUNOLOGY. (pp. 42 - 42). BLACKWELL PUBLISHING

Beresford, M and Lyburn, I and Sanghera, B and Makris, A and Wong, WL (2007) Serial integrated F-18-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma. BLACKWELL PUBLISHING

Beresford, MJ and Ravichandran, D and Makris, A (2007) Neoadjuvant endocrine therapy in breast cancer. Cancer Treatment Reviews , 33 (1) 48 - 57.

Brown, T and Taherbhai, Z and Sexton, J and Sutterfield, A and Turlington, M and Jones, J and Stallings, L and Stewart, M and Buchmueller, K and Mackay, H and O'Hare, C and Kluza, J and Nguyen, B and Wilson, D and Lee, M and Hartley, JA (2007) Synthesis and biophysical evaluation of minor-groove binding C-terminus modified pyrrole and imidazole triamide analogs of distamycin. BIOORGAN MED CHEM , 15 (1) 474 - 483. 10.1016/j.bmc.2006.09.037.

Buchler, T and Bomanji, J and Lee, SM (2007) FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin's disease--a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica , 92 (11) e120 - e121. 10.3324/haematol.11856.
An open access publication

Burdak-Rothkamm, S and Short, S and Folkard, M and Rothkamm, K and Prise, KM (2007) ATR-Dependent Radiation Induced g-H2AX Foci In Bystander Primary Human Astrocytes And Glioma Cells. Oncogene , 26 (7) 993 - 1002. 10.1038/sj.onc.1209863.

C

Chong, IY and Hoskin, PJ (2007) Vaginal vault brachytherapy for low risk endometrial carcinoma. In: CLINICAL ONCOLOGY. (pp. S8 - S8).

Chong, IY and Rojas, A and Hoskin, PJ (2007) Does a fall in lymphocyte or neutrophil count during chemoradiotherapy predict survival in cervical carcinoma? In: CLINICAL ONCOLOGY. (pp. S25 - S26).

Clingen, PH and Arlett, CF and Hartley, JA and Parris, CN (2007) Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links. EXP CELL RES , 313 (4) 753 - 760. 10.1016/j.yexcr.2006.11.007.

D

Dancey, G and Violet, J and Othman, S and Parker, S and Green, A and Sharma, S and Francis, R and Griffin, N and Chan, PS and Amlot, P and Malhotra, A and Woodward, N and Isaacson, P and Lister, TA and Buscombe, J and Begent, R and McNamara, C (2007) Phase I trial of the I-131-labelled Anti-CD25 antibody basiliximab in the treatment of patients with relapsed or refractory lymphoma. In: BLOOD. (pp. 199A - 200A). AMER SOC HEMATOLOGY

Dearling, JL and Pedley, RB (2007) Technological advances in radioimmunotherapy. Clin Oncol (R Coll Radiol) , 19 (6) 457 - 469. 10.1016/j.clon.2007.03.016.

Dearling, JLJ and Pedley, RB (2007) Technological advances in Radioimmunotherapy. CLIN ONCOL-UK , 19 (6) 457 - 469. 10.1016/j.cion.2007.03.016.

Dearling, JLJ and Qureshi, U and Begent, RHJ and Pedley, RB (2007) Combining radioimmunotherapy with antihypoxia therapy 2-deoxy-D-glucose results in reduction of therapeutic efficacy. CLIN CANCER RES , 13 (6) 1903 - 1910. 10.1158/1078-0432.CCR-06-2094.

Dearling, JLJAPRB (2007) Antibody directed radionuclide therapy. In: Hoskin, PJ, (ed.) Radiotherapy in Practice: Volume III Radioisotopes. (9 - 45). Oxford University Press.

Diez, P and Hoskin, PJ (2007) Conventional and CT-based volumes in IFRT for supradiaphragmatic malignant lymphoma. In: CLINICAL ONCOLOGY. (pp. S16 - S16).

E

El Emir, E and Qureshi, U and Dearling, JLJ and Boxer, GM and Clatworthy, I and Folarin, AA and Robson, MP and Nagl, S and Konerding, MA and Pedley, RB (2007) Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. CANCER RES , 67 (24) 11896 - 11905. 10.1158/0008-5472.CAN-07-2967.

El-Emir, E and Dearling, JLJ and Huhalov, A and Robson, MP and Boxer, G and Neri, D and van Dongen, GAMS and Trachsel, E and Begent, RHJ and Pedley, RB (2007) Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models. BRIT J CANCER , 96 (12) 1862 - 1870. 10.1038/sj.bjc.6603806.
An open access publication

El-Emir, E and Qureshi, U and Dearling, JLJ and Boxer, GM and Clatworthy, I and Folarin, AA and Robson, MP and Konerding, MA and Nagl, S and Pedley, RB (2007) Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas. Cancer Research , 67 2639 - 2646.

Ellis, T and Evans, DA and Martin, CRH and Hartley, JA (2007) A 96-well DNase I footprinting screen for drug-DNA interactions. NUCLEIC ACIDS RES , 35 (12) , Article e89. 10.1093/nar/gkm467.
An open access publication

F

Forster, MD and Ormerod, MG and Agarwal, R and Kaye, SB and Jackman, AL (2007) Flow cytometric method for determining folate receptor expression on ovarian carcinoma cells. Cytometry A , 71 (11) 945 - 950. 10.1002/cyto.a.20456.

Fox, J and Glasspool, D and Grecu, D and Modgil, S and South, M and Patkar, V (2007) Argumentation-based inference and decision making - A medical perspective. IEEE INTELL SYST , 22 (6) 34 - 41.

Funes, JM and Quintero, M and Henderson, S and Martinez, D and Qureshi, U and Westwood, C and Clements, MO and Bourboulia, D and Pedley, RB and Moncada, S and Boshoff, C (2007) Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. P NATL ACAD SCI USA , 104 (15) 6223 - 6228. 10.1073/pnas.0700690104.
An open access publication

H

Hochhauser, D and Kotecha, M and O'Hare, C and Morris, PJ and Hartley, JM and Taherbhai, Z and Harris, D and Forni, C and Mantovani, R and Lee, M and Hartley, JA (2007) Modulation of topoisomerase II alpha expression by a DNA sequence-specific polyamide. MOL CANCER THER , 6 (1) 346 - 354. 10.1158/1535-7163.MCT-06-0503.

Hochhauser, D and Kotecha, M and O'Hare, C and Morris, PJ and Hartley, JM and Taherbhai, Z and Harris, D and Forni, C and Mantovani, R and Lee, M and Hartley, JA (2007) Modulation of topoisomerase II expression in mammalian cells with a sequence-specific polyamide. Molecular Cancer Therapeutics , 6 (1) 346 - 354.

Hoskin, PJ and Bownes, P and Bryant, L and Ostler, P (2007) HDR monotherapy brachytherapy for localised prostate cancer. In: CLINICAL ONCOLOGY. (pp. S7 - S7).

Hoskin, PJ and Carnell, DM and Taylor, NJ and Smith, RE and Stirling, JJ and Daley, FM and Saunders, MI and Bentzen, SM and Collins, DJ and d'Arcy, JA and Padhani, AP (2007) Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 68 (4) 1065 - 1071.

Hoskin, PJ and Chin, Y and Wong, W and Rojas, A (2007) The value of SUV in FDG PET for lymphoma. In: CLINICAL ONCOLOGY. (pp. S32 - S32).

Hoskin, PJ and Dearnaley, DP (2007) Hypofractionation in clinical trials for prostate cancer. ELSEVIER SCIENCE LONDON

Hoskin, PJ and Motohashi, K and Bownes, P and Bryant, L and Ostler, P (2007) High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiotherapy & Oncology , 84 (2) 114 - 120.

Hoskin, PJ and Venselaar, J (2007) Prostate brachytherapy in Europe: Growth, practice and guidelines. UNSPECIFIED

Howie, AJ (2007) The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome. Transplantation , 83 (4) 373 - 374. 10.1097/01.tp.0000251424.65487.5c.

Huddart, RA and O'Doherty, MJ and Padhani, A and Rustin, GJ and Mead, GM and Joffe, JK and Vasey, P and Harland, SJ and Logue, J and Daugaard, G and Hain, SF and Kirk, SJ and MacKewn, JE and Stenning, SPNCRITTCSG (2007) 18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group. Clinical Oncology , 25 (11) 1310 - 1315.

J

Jain, P and Cerone, MA and Leblanc, AC and Autexier, C (2007) Telomerase and neuronal marker status of differentiated NT2 and SK-N-SH human neuronal cells and primary human neurons. J Neurosci Res , 85 (1) 83 - 89. 10.1002/jnr.21094.

Joerger, M and Huitema, ADR and Richel, DJ and Dittrich, C and Pavlidis, N and Briasoulis, E and Vermorken, JB and Strocchi, E and Martoni, A and Sorio, R and Sleeboom, HP and Izquierdo, MA and Jodrell, DI and Calvert, AH and Boddy, A and Hollema, H and Fety, R and Van der Vijgh, WJF and Hempel, G and Chatelut, E and Karlsson, M and Tranchand, B and Schrijvers, AHGJ and Beijnen, JH and Schellens, JHM (2007) Population PKPD of paclitaxel and carboplatin in ovarian cancer patients: A study by the EORTC-PAMM-NDDG. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , 63 (4) 505 - 505.

Joerger, M and Huitema, ADR and Richel, DJ and Dittrich, C and Pavlidis, N and Briasoulis, E and Vermorken, JB and Strocchi, E and Martoni, A and Sorio, R and Sleeboom, HP and Izquierdo, MA and Jodrell, DI and Calvert, H and Boddy, AV and Hollema, H and Fety, R and Van der Vijgh, WJF and Hempel, G and Chatelut, E and Karlsson, M and Wilkins, J and Tranchand, B and Schrijvers, AHGJ and Twelves, C and Beijnen, JH and Schellens, JHM (2007) Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: A study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group. CLIN CANCER RES , 13 (21) 6410 - 6418. 10.1158/1078-0432.CCR-07-0064.

Judith, D (2007) CT scan plan to combat cancer. Sunday Herald

K

Kandola, S and Anyamene, N and Payne, H and Harland, S (2007) Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer: a bad experience. BJU International , 99 (1) 53 - 55.

Kiakos, K and Sato, A and Asao, T and McHugh, PJ and Lee, M and Hartley, JA (2007) DNA sequence-selective adenine alkylation, mechanism of adduct repair, and in vivo antitumor activity of the novel achiral seco-amino-cyclopropylbenz[e]indolone analogue of duocarmycin AS-I-145. MOL CANCER THER , 6 (10) 2708 - 2718. 10.1158/1535-7163.MCT-07-0294.

Kogelberg, H and Sharma, SK and Qureshi, U and Tolner, B and Lowdell, M and Shabakhti, H and Robson, M and Pedley, RB and Begent, RHJ and Chester, KA (2007) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 65 - ?).

Kogelberg, H and Tolner, B and Sharma, SK and Lowdell, MW and Qureshi, U and Robson, M and Hillyer, T (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy (vol 17, pg 36, 2007). GLYCOBIOLOGY , 17 (10) 1030 - 1030. 10.1093/glycob/cw1053.

Kogelberg, H and Tolner, B and Sharma, SK and Lowdell, MW and Qureshi, U and Robson, M and Hillyer, T and Pedley, RB and Vervecken, W and Contreras, R and Begent, RHJ and Chester, KA (2007) Clearance mechanism of a mannosylated antibody-enzyme fusion protein used in experimental cancer therapy. GLYCOBIOLOGY , 17 (1) 36 - 45. 10.1093/glycob/cwl053.

Kogelberg, H and Tolner, B and Thomas, G and Di Cara, D and Ramesh, B and Sodha, S and Lowdell, M and Meyer, T and Begent, R and Hart, I and Marshall, J and Chester, K (2007) Generation of a single-chain Fv with binding specificity for the integrin, alpha v beta 6, by rational structure based antibody engineering – a promising agent for cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

Koukourakis, MI and Bentzen, SM and Giatromanolaki, A and Wilson, GD and Daley, FM and Saunders, MI and Dische, S and Sivridis, EA and Harris, AL (2007) Endogenous markers of two separate hypoxia response pathways (HIF2 alpha and CA9) predict radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) 727 - 735. 10.1200/jco.2005.02.7474.

Kulkarni, AA and Loddo, M and Leo, E and Rashid, M and Eward, KL and Fanshawe, TR and Butcher, J and Frost, A and Ledermann, JA and Williams, GH and Stoeber, K (2007) DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. CLIN CANCER RES , 13 (20) 6153 - 6161. 10.1158/1078-0432.CCR-07-0671.

L

Ladenstein, R and Whelan, J and Oberlin, O and Weston, C and Jurgens, H (2007) Multivariate analysis based risk grouping of Ewing tumours (ET) with extra-pulmonary metastatic disease (EPMD): Final results from the Euro Ewing 99 study. In: ASCO Chicago 2007.

Lai, P and Bomanji, JB and Mahmood, S and Nagabhushan, N and Syed, R and Gacinovic, S and Lee, SM and Ell, PJ (2007) Detection of tumour thrombus by 18F-FDG-PET/CT imaging. Eur J Cancer Prev , 16 (1) 90 - 94. 10.1097/01.cej.0000220641.46470.77.

Lankester, KJ and Maxwell, RJ and Pedley, RB and Dearling, JL and Qureshi, UA and El-Emir, E and Hill, SA and Tozer, GM (2007) Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, I-131-A5B7, even at doses that are sub-optimal for vascular shut-down. INT J ONCOL , 30 (2) 453 - 460.

Latz, J and Adachi, S and Symanowski, J and Nakagawa, K and Tamura, T and Hanna, N and Cullen, M and Falcoz, C and Musib, L and Calvert, H (2007) Correlation of pemetrexed (PEM) NSCLC exposure-response relationships (ERRS) to clinical study results from western and Japanese patient populations. J THORAC ONCOL , 2 (8) S455 - S456.

Ledermann, JA and Gabra, H and Jayson, GC and Spanswick, VJ and Rustin, GJ and Jitlal, M and James, LE and Hartley, JA (2007) Combination chemotherapy with carboplatin and gemcitabine in patients in platinum-resistant ovarian cancer chemotherapy: a phase II study demonstrating inhibition of DNA cross-link repair by gemcitabine. In: EJC SUPPLEMENTS. (pp. 320 - 320). PERGAMON-ELSEVIER SCIENCE LTD

Lee, SM and Woll, PJ and James, LJ and Hatton, M and Ali, K and Spiro, SG and Ali, SR and Hackshaw, A (2007) A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC). In: (Proceedings) Presidential Symposium. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S306 - S307). Journal of Thoracic Oncology

Lee, SM and Woll, PJ and Rudd, and RM, and Gower, NH and Ottensmeier, CH and Ali, K and Spiro, SG and Hatton, M and Ali, K and Spiro, SG and Hackshaw, A (2007) A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC). In: (Proceedings) Proffered Paper. 12th World Conference on Lung Cancer, Seoul, Korea.. (pp. S359 - ?). Journal of Thoracic Oncology

Lewis, IJ and Nooij, MA and Whelan, J and Sydes, MR and Grimer, R and Hogendoorn, PCW and Memon, MA and Weeden, S and Uscinska, BM and van Glabbeke, M and Kirkpatrick, A and Hauben, EI and Craft, AW and Taminiau, AHM (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. Journal of the National Cancer Institute , 99 (2) 112 - 128.

Lewis, IJ and Nooij, MA and Whelan, J and Sydes, MR and Grimer, R and Hogendoorn, PCW and Memon, MA and Weeden, S and Uscinska, BM and van Glabbeke, M and Kirkpatrick, A and Hauben, EI and Craft, AW and Taminiau, AHM and MRC BO06 Collaborators, and EORTC 80931 Collaborators, and European Osteosarcoma Intergrp, (2007) Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup. J NATL CANCER I , 99 (2) 112 - 128. 10.1093/inci/djk015.

Lowe, H and Tolner, B and Kogelberg, H and Begent, R and Robson, L and Taylorson, C and Chester, K (2007) A novel human enzyme with a bis-chloro-phenol prodrug for Antibody Directed Enzyme Prodrug Therapy (ADEPT). In: (Proceedings) NCRI Cancer Conference Proceedings.

Lucy, M (2007) Why I didn’t have any qualms about taking thalidomide. The Express 56 - ?.

M

Mandeville, HC and Ng, Q and Milner, J and Taylor, NJ and Stirling, JJ and Padhani, AR and d'Arcy, AJ and Collins, DJ and Saunders, MI and Hoskin, PJ (2007) CA4P and external beam radiotherapy in prostate cancer with assessment of effect by DCE-MRI. In: CLINICAL ONCOLOGY. (pp. S38 - S38).

Marelli, L and Stigliano, R and Triantos, C and Senzolo, M and Cholongitas, E and Davies, N and Tibballs, J and Meyer, T and Patch, DW and Burroughs, AK (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol , 30 (1) 6 - 25. 10.1007/s00270-006-0062-3.

Marina, N and S Bielack, MS and M Bernstein, TB-B and S Smeland, AH and Whelan, J (2007) International collaboration is feasible in trials for rare conditions: the EURAMOS experience. In: ASCO Chicago. (pp. Abstract 2 - ?).

Marsh, D and Vigor, K and Kogelberg, H and Tolner, B and Meyer, T and Begent, R and Chana, J and Marshall, J and Thomas, G and Hart, I and Kyrtatos, P and Lythgoe, M and Pankhurst, Q and Chester, K (2007) Antibody targeted magnetic nanoparticles for cancer imaging and therapy. In: (Proceedings) NCRI Cancer Conference Proceedings.

N

Nehls, O and Okech, T and Hsieh, CJ and Enzinger, T and Sarbia, M and Borchard, F and Gruenagel, HH and Gaco, V and Hass, HG and Arkenau, HT and Hartmann, JT and Porschen, R and Gregor, M and Klump, B (2007) Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer , 96 (9) 1409 - 1418. 10.1038/sj.bjc.6603728.

Ng, F and Mastoroudes, H and Paul, E and Davies, N and Tibballs, J and Hochhauser, D and Mayer, A and Begent, R and Meyer, T (2007) A comparison of hickman line- and port-a-cath-associated complications in patients with solid tumours undergoing chemotherapy. CLIN ONCOL-UK , 19 (7) 551 - 556. 10.1016/j.clon.2007.04.003.

Ng, Q-S and Goh, V and Milner, J and Stratford, MR and Folkes, LK and Tozer, GM and Saunders, MI and Hoskin, PJ (2007) Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. The Lancet Oncology , 8 (2) 111 - 118. 10.1016/S1470-2045(07)70001-3.

Ng, QS and Goh, V and Carnell, D and Meer, K and Padhani, AR and Saunders, MI and Hoskin, PJ (2007) Tumor antivascular effects of radiotherapy combined with combretastatin A4 phosphate in human non-small-cell lung cancer. International Journal of Radiation Oncology Biology Physics , 67 (5) 1375 - 1380.

Ng, QS and Goh, V and Milner, J and Padhani, AR and Saunders, MI and Hoskin, PJ (2007) Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. International Journal of Radiation Oncology Biology Physics , 67 (2) 417 - 424.

O

O'Hare, CC and Uthe, P and Mackay, H and Blackmon, K and Jones, J and Brown, T and Nguyen, B and Wilson, WD and Lee, M and Hartley, JA (2007) Sequence recognition in the minor groove of DNA by covalently linked formamido imidazole-pyrrole-imidazole polyamides: Effect of H-pin linkage and linker length on selectivity and affinity. BIOCHEMISTRY-US , 46 (42) 11661 - 11670. 10.1021/bi701053a.

P

Penn, H and Howie, AJ and Kingdon, EJ and Bunn, CC and Stratton, RJ and Black, CM and Burns, A and Denton, CP (2007) Scleroderma renal crisis-patient characteristics and outcomes in 110 cases from a single centre. In: RHEUMATOLOGY. (pp. I4 - I5). OXFORD UNIV PRESS

Penn, H and Howie, AJ and Kingdon, EJ and Bunn, CC and Stratton, RJ and Black, CM and Burns, A and Denton, CP (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM-INT J MED , 100 (8) 485 - 494. 10.1093/qjmed/hcm052.

Pepper, C and Lowe, H and Fegan, C and Thurieau, C and Thurston, DE and Hartley, JA and Delavault, P (2007) Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cells. BRIT J CANCER , 97 (2) 253 - 259. 10.1038/sj.bjc.6603853.

Plummer, ER and Calvert, H (2007) Targeting poly(ADP-ribose) polymerase: A two-armed strategy for cancer therapy. CLIN CANCER RES , 13 (21) 6252 - 6256. 10.1158/1078-0432.CCR-07-0617.

Plummer, R and Attard, G and Pacey, S and Li, L and Razak, A and Perrett, R and Barrett, M and Judson, I and Kaye, S and Fox, NL and Halpern, W and Corey, A and Calvert, H and De Bono, J (2007) Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers. CLIN CANCER RES , 13 (20) 6187 - 6194. 10.1158/1078-0432.CCR-07-0950.

Plummer, R and Vida, L and Perrett, R and Spicer, J and Stopfer, P and Shahidi, M and Temple, G and Futreal, A and Calvert, H and de Bono, J (2007) A phase I and pharmacokinetic (PK) study of BIBW 2992, an oral irreversible dual EGFR/HER2 inhibitor. In: EJC SUPPLEMENTS. (pp. 108 - 108). PERGAMON-ELSEVIER SCIENCE LTD

Porschen, R and Arkenau, H-T and Kubicka, S and Greil, R and Seufferlein, T and Freier, W and Kretzschmar, A and Graeven, U and Grothey, A and Hinke, A and Schmiegel, W and Schmoll, H-J (2007) In reply [10]. Journal of Clinical Oncology , 25 (31) 5045 - 5046.

Porschen, R and Arkenau, H-T and Kubicka, S and Greil, R and Seufferlein, T and Freier, W and Kretzschmar, A and Graeven, U and Grothey, A and Hinke, A and Schmiegel, W and Schmoll, H-J (2007) In reply [8]. Journal of Clinical Oncology , 25 (31) 5042 - 5043.

Porschen, R and Arkenau, HT and Kubicka, S and Greil, R and Seufferlein, T and Freier, W and Kretzschmar, A and Graeven, U and Grothey, A and Hinke, A and Schmiegel, W and Schmoll, HJ and AIO Colorectal Study Group, (2007) Phase III study of capecitabine plus oxaliplatin compared with fluorouracil and leucovorin plus oxaliplatin in metastatic colorectal cancer: a final report of the AIO Colorectal Study Group. J Clin Oncol , 25 (27) 4217 - 4223. 10.1200/JCO.2006.09.2684.

R

Rachid, Z and Brahimi, F and Qiu, Q and Williams, C and Hartley, JM and Hartley, JA and Jean-Claude, BJ (2007) Novel nitrogen mustard-armed combi-molecules for the selective targeting of epidermal growth factor receptor overexperessing solid tumors: Discovery of an unusual structure-activity relationship. J MED CHEM , 50 (11) 2605 - 2608. 10.1021/jm070144p.

Rades, D and Veninga, T and Stalpers, LJ and Basic, H and Hoskin, PJ and Karstens, JH and Schild, SE and Dunst, J (2007) Improved posttreatment functional outcome is associated with better survival in patients irradiated for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys , 67 (5) 1506 - 1509. 10.1016/j.ijrobp.2006.11.029.

Ravn, P and Patel, A and Bicknell, R and Begent, RHJ and Pedley, and R, B and Chester, KA and Meyer, T (2007) UNSPECIFIED In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 59 - ?).

Roylance, R and Seddon, B and McTiernan, A and Sykes, K and Daniels, S and Whelan, J (2007) Experience of the use of trabectedin (ET-743, Yondelis (TM)) in 21 patients with pre-treated advanced sarcoma from a single centre. CLIN ONCOL-UK , 19 (8) 572 - 576. 10.1016/j.cton.2007.05.006.

Roylance, R and Seddon, BM and Sykes, K and Beresford, A and Daniels, S and Whelan, J (2007) Experience of the use of trabectedin (ET-743, Yondelis) in twenty one patients with pre-treated advanced sarcoma from a single centre. Clinical Oncology , 19 (8) 572 - 576. 10.1016/j.clon.2007.05.006.

Rustin, GJ and Mead, GM and Stenning, SP and Vasey, PA and Aass, N and Huddart, RA and Sokal, MP and Joffe, JK and Harland, SJ and Kirk, SJ (2007) Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197 - The National Cancer Research Institute Testis Cancer Clinical Studies Group. JOURNAL OF CLINICAL ONCOLOGY , 25 (11) 1310 - 1315. 10.1200/JCO.2006.08.4889.

S

Sainz-Pastor, N and Tolner, B and Robson, L and Parizek, P and Binz, K and Forrer, P and Begent, R and Plückthun, A and Chester, K (2007) Selection and evaluation of designed ankyrin repeat proteins (DARPins) reactive with carcinoembryonic antigen (CEA). In: (Proceedings) NCRI Cancer Conference Proceedings.

Sexton, J and Mackay, H and Brown, T and Kotecha, M and O'Hare, C and Kluza, J and Hochhauser, D and Hartley, J and Nguyen, B and Wilson, D and Lee, M (2007) MEDI 309-Regulation of the topoisomerase II alpha gene using polyamides that binds to the inverted CCAAT box present in the promoter. ABSTR PAP AM CHEM S , 234 ? - ?.

Short, SC and Buffa, FM and Bourne, S and Koritzinsky, M and Wouters, BG and Bentzen, SM (2007) Dose- and time-dependent changes in gene expression in human glioma cells after low radiation doses. RADIATION RESEARCH , 168 (2) 199 - 208. 10.1667/RR0940.1.

Short, SC and Martindale, C and Bourne, S and Brand, J and Johnston, P (2007) DNA damage response in gliomas and normal human astrocytes. Neuro-Oncology , 9 (4) 404 - 411.

Short, SC and Martindale, C and Bourne, SM and Brand, G and Woodcock, M and Johnston, P (2007) Damage signalling after TMZ and radiation in glioma cells and sensitisation by inhibition of repair in G2. In:

Sielaff, A and Cooper, A and Mackay, H and Brown, T and O'Hare, C and Kluza, J and Kotecha, M and Le, M and Hochhauser, D and Hartley, JA and Lee, M (2007) Binding of f-PIP and JH-37 to the inverted CCAAT box-2 of the topoisomerase II promoter. ABSTR PAP AM CHEM S , 233 613 - 613.

Sikic, BI and Wakelee, HA and Von Mehren, M and Lewis, NL and Plummer, ER and Calvert, AH and Fox, NL and Kumm, EA and Jones, SF and Burris, HA (2007) A phase 1b study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI. MOL CANCER THER , 6 (12) 3454S - 3455S.

Sky, NRSM (2007) Thalidomide could get cancer treatment licence. UNSPECIFIED

Smith, AE and Pinkney, M and Piggott, NH and Calvert, H and Milton, ID and Lunec, J (2007) Novel monoclonal antibody for detection of folate receptor alpha in paraffin-embedded tissues. HYBRIDOMA , 26 (5) 281 - 288. 10.1089/hyb.2007.0512.

Spicer, J and Calvert, H and Vidal, L and Azribi, F and Perrett, R and Shahidi, M and Temple, G and Futreal, A and De Bono, J and Plummer, R (2007) Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR. J THORAC ONCOL , 2 (8) S410 - S410.

Swanton, C and Marani, M and Pardo, O and Warne, PH and Kelly, G and Sahai, E and Elustondo, F and Chang, J and Temple, J and Ahmed, AA and Brenton, JD and Downward, J and Nicke, B (2007) Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell , 11 (6) 498 - 512. 10.1016/j.ccr.2007.04.011.

T

Tolner, B and Smith, L and Hillyer, T and Bhatia, J and Beckett, P and Robson, L and Sharma, SK and Griffin, N and Vervecken, W and Contreras, R and Pedley, RB and Begent, RHJ and Chester, KA (2007) From laboratory to Phase I/II cancer trials with recombinant biotherapeutics. EUR J CANCER , 43 (17) 2515 - 2522. 10.1016/j.ejca.2007.08.027.

Toumpanakis, C and Meyer, T and Caplin, ME (2007) Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab , 21 (1) 131 - 144. 10.1016/j.beem.2007.01.005.

V

Vassileva, V and Grant, J and De Souza, R and Allen, C and Piquette-Miller, M (2007) Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. CANCER CHEMOTH PHARM , 60 (6) 907 - 914. 10.1007/s00280-007-0449-0.

W

Westbury, CB and Pearson, A and Nerurkar, A and Reis-Filho, JS and Steele, D and Peckitt, C and Sharp, G and Yarnold, JR (2007) Hypoxia can be detected in irradiated normal human tissue: a study using the hypoxic marker pimonidazole hydrochloride. BRIT J RADIOL , 80 (959) 934 - 938. 10.1259/bjr/25046649.

Whelan, J and Dolbear, C and Mak, V and Moller, H and Davies, E (2007) Where do teenagers and young adults receive treatment for cancer? J PUBLIC HEALTH-UK , 29 (2) 178 - 182. 10.1093/pubmed/fdm006.

Whelan, J and Smeland, S and Marina, N and Bernstein, M and Sydes, MR and Butterfass-Bahoul, T and Perisoglou, M and Carrle, D and Bielack, S (2007) Successful pan-European and trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECTEUROCORES). In: ). European Journal of Cancer Supplements 5:408-409, 2007. (Abstract).

Whelan, J and Smeland, S and Marina, N and Bernstein, M and Sydes, MR and May, B and Butterfass-Bahloui, T and Perisoglou, M and Carrle, D and Bielack, S (2007) Successful pan-European and trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES). In: EJC SUPPLEMENTS. (pp. 408 - 409). PERGAMON-ELSEVIER SCIENCE LTD

Whelan, J and Smeland S, MN and Bernstein M, SM and May E, B-BT and Perisoglou M, CD and Calaminus G, MR and Hogendoorn P, UB and Bielack, S (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In: National Cancer Research Institute Cancer Conference, Birmingham.

Whelan, J and Sydes, M and Bielack, S and Smeland, S and Marina, N and May, E and Butterfass-Bahloul, T and Morgan, R and Perisoglou, M and Carrle, D and Bernstein, M (2007) Successful trans-Atlantic collaboration in a randomised controlled trial in osteosarcoma: EURAMOS1 (ISRCTN67613327; a trial conducted as part of ECT-EUROCORES) – a potential model for collaboration in rare diseases. In: British Sarcoma Group meeting 2008 conference abstracts http://www.bsgconference.org.uk/abst2008/absp-sydes.pdf:.

Whelan, JLI and Nooij M, SM and Grimer R, HP and Memon M, WS and Uscinska B, VGM and Kirkpatrick A, HE and Craft A, TOBOTMRCBO06AEORTC80931CAEOI (2007) Intensified chemotherapy improved histological response but not survival in patients with operable osteosarcoma of an extremity: results of a randomised phase III study of the European Osteosarcoma Intergroup (MRC BO06 80931 ISRCTN86294690). Journal of the National Cancer Institute , 99 112 - 128.

Whelan, JS and Fern, L (2007) Cancer in adolescence: Incidence and policy issues. In: Kelly, D and Gibson, F, (eds.) Cancer in Adolescents and Young People: Care and Policy Issues. Blackwell: Oxford.

Wilkins, D and Mayer, A and Sharma, S and Tolner, B and Springer, C and Hartley, J and Boxer, G and Bell, J and Green, A and Francis, R and Grudus, E and Chester, K and Begent, R (2007) Interim Results of a Phase I/II Trial of Antibody Directed Enzyme Prodrug Therapy (ADEPT) in Patients with Gastrointestinal Carcinoma. In: (Proceedings) NCRI Cancer Conference Proceedings.

Wood, K and Saunders, MI and Honess, DJ and Maxwell, RJ and Wilson, J and Paul, RL and Marsden, PK and O'Doherty, MJ and Blower, PJ (2007) Evaluation of the effects of blood flow on 64Cu-ATSM distribution in a rodent tumour model. In: Radiotherapy & Oncology. (pp. S35 - S36).

Wood, KA and Hoskin, PJ and Saunders, MI (2007) Positron emission tomography in oncology: A review. CLIN ONCOL-UK , 19 (4) 237 - 255. 10.1016/j.clon.2007.02.001.

Wylie, JP and Mandall, P and Bottomley, D and Hoskin, PJ (2007) Multi-institutional UK prostate brachytherapy database. In: CLINICAL ONCOLOGY. (pp. S50 - S51).

Wynne, P and Newton, C and Ledermann, J and Olaitan, A and Mould, TA and Hartley, JA (2007) Enhanced repair of DNA interstrand crosslinking in ovarian cancer cells from patients following treatment with platinum-based chemotherapy. BRIT J CANCER , 97 (7) 927 - 933. 10.1038/sj.bjc.6603973.

Y

Yogev, O and Karniely, S and Pines, O (2007) Translation-coupled translocation of yeast fumarase into mitochondria in vivo. J BIOL CHEM , 282 (40) 29222 - 29229. 10.1074/jbc.M704201200.
An open access publication

This list was generated on Thu May 23 09:24:21 2013 BST.